Refine your search
443 results found
Sheppard Mullin Richter & Hampton LLP | USA | 12 May 2023
DEA and SAMHSA Extend Tele-Prescribing Flexibilities
This week, the Drug Enforcement Administration (“DEA”), in conjunction with the Substance Abuse and Mental Health Services Administration (“SAMHSA”)…
Riker Danzig LLP | USA | 11 May 2023
DEA Extension of Telemedicine Prescribing and Latest DSH Allotments
After loosening the in-person requirements in prescribing controlled substances (“CDs”) during COVID-19, the Drug Enforcement Administration ("DEA")…
Benesch Friedlander Coplan & Aronoff LLP | USA | 4 May 2023
DEA Permits Continuation of Telemedicine Controlled Substances Prescribing: A Temporary Pause of the Proposed Rules or a Fundamental Change?
Earlier this year in late February, the Drug Enforcement Administration (DEA) announced proposed rules attempting to change the rules for…
Bradley Arant Boult Cummings LLP | USA | 14 Mar 2023
DEA Issues Proposed Rule for Prescribing of Controlled Substances via Telemedicine
On March 1, 2023, the Drug Enforcement Administration (DEA) released the proposed rule, "Telemedicine Prescribing of Controlled Substances When the…
Bradley Arant Boult Cummings LLP | USA | 9 Mar 2023
Real or Not Real? The Difference Between Legal Delta-8/Delta-10 THC and Illegal Delta-8/Delta-10 THCO
Last week, we wrote about the Drug Enforcement Administration’s (DEA) February 13, 2023 response letter stating that delta-8 THCO and delta-9 THCO -…
McDermott Will & Emery | USA | 28 Feb 2023
DEA Proposes Limited Post-PHE Telemedicine Prescription of Controlled Substances
On February 24, 2023, the US Drug Enforcement Administration (DEA) issued two proposed rules (the Telemedicine Controlled Substance Proposed Rule and…
Bradley Arant Boult Cummings LLP | USA | 23 Feb 2023
THC-Oh No! The DEA Classifies Delta-8 and Delta-9 THCO as Controlled Substances
In the summer of August 2022, and again in February 2023, a North Carolina attorney wrote to the Drug Enforcement Administration (DEA) to ask about…
Cote Law PLLC | USA | 20 Feb 2023
A Distributor’s Conundrum: When DEA and state law collide
In a highly regulated industry, such as controlled substance distribution, having clarity of regulatory requirements facilitates implementation and…
Duane Morris LLP | USA | 16 Feb 2023
DEA Finds that Lab-Derived Cannabis Compounds Are a Schedule I Drug, Even if Made from Hemp
On February 13, 2023, the U.S. Drug Enforcement Administration (DEA) published a letter in which it opined that two acetate compounds chemically…
Akerman LLP | USA | 16 Feb 2023
May Resident Physicians Use Hospital DEA Registration Numbers Off-Site?
A Florida “resident physician” is someone who has completed their internship and graduated from medical school but is not yet licensed as a Florida…
